The court's order came on the plea by Novartis, represented through advocate Mamta Jha, seeking to restrain other pharma firms from manufacturing or selling the patented combination of Sacubitril and Valsartan tablets.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3CKbzTm
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» HC restrains generic pharma firms from making, selling patent drug of Novartis
https://ift.tt/eA8V8J
No comments:
Post a Comment